Nurseify is an on-demand platform that allows nurses and health care organizations to take part in the gig economy. Photo via unsplash.com

Health care executive Benjamin Foster knows that nurses are essential — especially in times of crisis.

In 2017, when Hurricane Harvey struck Houston, he watched as local health care organizations struggled to find nurses who could meet the desperate need at hard-to-reach facilities. And as Regional Chief Human Resources Officer at HCA Houston Healthcare, he had also grown accustomed to the high costs and inefficiencies of traditional medical staffing agencies.

In 2020, in response to the demand for nurses in the pandemic, he decided it was time to act, launching Nurseify in May of that year.

Nurseify is an on-demand platform that allows nurses and health care organizations to take part in the gig economy.With guidance from Rama Walker, Nurseify’s Chief Nursing Officer and Chief Operating Officer with a background in ER administration, the platform uses AI to match nurses with facilities looking to fill short-term assignments.

Nurses are able to set their rates and schedules through the app. Health care facilities can directly vet applicants through their profiles and ratings. The platform also can predict when there might be a higher demand for contract nurses at various facilities based on vacancies and increased patient volume.

“We hope to empower nurses and help individuals take control of their careers by offering transparency and a way to create schedules to better fit their lifestyles,” says Foster, CEO of Nurseify, in a statement. “In this gig-economy, it’s imperative to have an easy and effective way for nurses and healthcare facilities to communicate directly about opportunities, and Nurseify provides a place where they can do just that.”

Additionally, the platform features educational, financial, and support resources for nurse users, as well as options to work with entrepreneurial mentors and wellness coaches with the goal of empowering nurses in what's proven to be a demanding field, especially since the onset of the pandemic.

“As nurse advocates, we prioritize an honest hiring process and nurses’ work-life balance and overall wellbeing,” Walker adds in a statement.

According to the Nurseify team, more than 5,000 nurses have created profiles on the platform at press time; and 60 healthcare facilities have access to Nurseify.

Through the Nuresify mobile app, which launches in May, the company aims to attract more users and health care facilities.

Currently the company is focused on its operations in Texas, Georgia, Florida, and South Carolina, which were pilot states for Nurseify. But the company aims to expand nationally and internationally in the future.

Houston-based acute care startup Kare Technologies launched a similar platform for staffing within the senior living facility and caregiving realms in 2021. Read more about that company here.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Intel Corp. and Rice University sign research access agreement

innovation access

Rice University’s Office of Technology Transfer has signed a subscription agreement with California-based Intel Corp., giving the global company access to Rice’s research portfolio and the opportunity to license select patented innovations.

“By partnering with Intel, we are creating opportunities for our research to make a tangible impact in the technology sector,” Patricia Stepp, assistant vice president for technology transfer, said in a news release.

Intel will pay Rice an annual subscription fee to secure the option to evaluate specified Rice-patented technologies, according to the agreement. If Intel chooses to exercise its option rights, it can obtain a license for each selected technology at a fee.

Rice has been a hub for innovation and technology with initiatives like the Rice Biotech Launch Pad, an accelerator focused on expediting the translation of the university’s health and medical technology; RBL LLC, a biotech venture studio in the Texas Medical Center’s Helix Park dedicated to commercializing lifesaving medical technologies from the Launch Pad; and Rice Nexus, an AI-focused "innovation factory" at the Ion.

The university has also inked partnerships with other tech giants in recent months. Rice's OpenStax, a provider of affordable instructional technologies and one of the world’s largest publishers of open educational resources, partnered with Microsoft this summer. Google Public Sector has also teamed up with Rice to launch the Rice AI Venture Accelerator, or RAVA.

“This agreement exemplifies Rice University’s dedication to fostering innovation and accelerating the commercialization of groundbreaking research,” Stepp added in the news release.

Houston team develops low-cost device to treat infants with life-threatening birth defect

infant innovation

A team of engineers and pediatric surgeons led by Rice University’s Rice360 Institute for Global Health Technologies has developed a cost-effective treatment for infants born with gastroschisis, a congenital condition in which intestines and other organs are developed outside of the body.

The condition can be life-threatening in economically disadvantaged regions without access to equipment.

The Rice-developed device, known as SimpleSilo, is “simple, low-cost and locally manufacturable,” according to the university. It consists of a saline bag, oxygen tubing and a commercially available heat sealer, while mimicking the function of commercial silo bags, which are used in high-income countries to protect exposed organs and gently return them into the abdominal cavity gradually.

Generally, a single-use bag can cost between $200 and $300. The alternatives that exist lack structure and require surgical sewing. This is where the SimpleSilo comes in.

“We focused on keeping the design as simple and functional as possible, while still being affordable,” Vanshika Jhonsa said in a news release. “Our hope is that health care providers around the world can adapt the SimpleSilo to their local supplies and specific needs.”

The study was published in the Journal of Pediatric Surgery, and Jhonsa, its first author, also won the 2023 American Pediatric Surgical Association Innovation Award for the project. She is a recent Rice alumna and is currently a medical student at UTHealth Houston.

Bindi Naik-Mathuria, a pediatric surgeon at UTMB Health, served as the corresponding author of the study. Rice undergraduates Shreya Jindal and Shriya Shah, along with Mary Seifu Tirfie, a current Rice360 Global Health Fellow, also worked on the project.

In laboratory tests, the device demonstrated a fluid leakage rate of just 0.02 milliliters per hour, which is comparable to commercial silo bags, and it withstood repeated disinfection while maintaining its structure. In a simulated in vitro test using cow intestines and a mock abdominal wall, SimpleSilo achieved a 50 percent reduction of the intestines into the simulated cavity over three days, also matching the performance of commercial silo bags. The team plans to conduct a formal clinical trial in East Africa.

“Gastroschisis has one of the biggest survival gaps from high-resource settings to low-resource settings, but it doesn’t have to be this way,” Meaghan Bond, lecturer and senior design engineer at Rice360, added in the news release. “We believe the SimpleSilo can help close the survival gap by making treatment accessible and affordable, even in resource-limited settings.”